Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
HQ
Founded
1910
Abbott Ventures (AVI) is a venture capital firm that primarily invests in emerging medical technology companies. AVI targets various stages of development, with a particular interest in development-stage companies within the medical devices, drug/device combinations, diagnostics, and unique drug delivery technologies sectors. The firm typically engages in Series A, B, and C funding rounds, reflecting its focus on companies poised for significant growth and innovation in the healthcare industry.
Notable portfolio companies include Bigfoot Biomedical, Howard University, Hydra Biosciences, Ovalis, and Setpoint Medical. AVI's investment philosophy centers on fostering long-term strategic growth options for Abbott Laboratories, leveraging its deep expertise in the healthcare sector. The firm offers unique value-add services to its portfolio companies, including strategic guidance and access to Abbott's extensive resources and networks. Key decision-makers at AVI bring a wealth of experience from their affiliations with leading healthcare and medical device companies.
1
As of August 24, 2024
Also Known As
Abbott Ventures
Operating Status
Active
Abbott Ventures Address
Delaware
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts